Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 12Glioblastoma 12Carcinoma, Non-Small-Cell Lung 12Prostatic Neoplasms 11Oropharyngeal Neoplasms 10Breast Neoplasms 10Glioma 8Urinary Bladder Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Esophageal Neoplasms 6Sarcoma 5Neoplasm Metastasis 5Mouth Neoplasms 5Carcinoma 5Burkitt Lymphoma 5Astrocytoma 5Uterine Cervical Neoplasms 4Rhabdomyosarcoma 4Pancreatic Neoplasms 4Liposarcoma 4Laryngeal Neoplasms 4Histiocytoma, Malignant Fibrous 4Gliosarcoma 4Carcinoma, Hepatocellular 4Brain Neoplasms 4Adenocarcinoma of Lung 4Adenocarcinoma Of Esophagus 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Sarcoma, Synovial 3

Interventions

Radiotherapy, Conformal 2Radiotherapy 2Paclitaxel 2Nivolumab 2Carboplatin 2veliparib 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Platinum 1Metformin 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Docetaxel 1Disulfides 1Cisplatin 1CTLA-4 Antigen 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Bronchiolo-Alveolar × Radiation × 90 days × Clear all
NCT00334815 2026-05-26

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Active not recruiting
29 enrolled 10 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡